Search
-
Press releaseAseBio calls for a Biotech Act I with greater funding, regulatory agility, and a stronger ...
We welcome the overall regulatory proposal, but believe it requires greater ambition, specificity, and implementation capacity. We advocate for a Biotech Act I that genuinely improves access to
-
Press releaseBizkaia hosts BIOSPAIN 2026, turning the Basque Country into a European hub for biotechnol...
The Bilbao Exhibition Centre will host the next edition of BIOSPAIN from September 29 to October 1. Under the slogan “Bioinnovation that clicks,” the congress will feature a program focused on health
-
Press releaseGreen Innovation Forum brings together leading professionals and companies from the biotec...
The event, organized by AseBio and the Salamanca City Council, was held this Tuesday at the Congress and Exhibition Center of the Tormes capital. It brought together 120 attendees from 75
-
Press releaseMTBVAC moves toward its final stage: the vaccine candidate that could mark a turning point...
According to WHO and ECDC data, 161,569 cases were reported in 2024 across 51 of the 53 countries in the European region, equivalent to 17.2 cases per 100,000 inhabitants. One of the main challenges
-
Press releaseDiana Morant, Minister for Science, Innovation and Universities: “Biotechnology is a strat...
The Spanish Bioindustry Association (AseBio) has organized a conference at the Ministry of Science that brought together leading institutional, political, and industry stakeholders to present a
-
Press releaseMore than 60% of biotech R&D staff are women, who represent 29% of management teams
Although the biotech sector is at the forefront, we still face persistent structural barriers that hinder women’s retention, promotion, and leadership in science and technology. Globally, fewer than
-
Press releaseThe new European Regulation on unsold products highlights the role of biotechnology in dri...
The regulation requires companies to transparently report unsold or discarded products, including quantities, causes, treatment, and prevention measures. For the biotechnology sector, it represents
-
Press releaseChildhood Cancer Needs Greater Awareness and Stable Funding to Accelerate Innovative Thera...
In Spain, around 1,500 cases of childhood cancer are diagnosed each year (1% of the total), making research more challenging and requiring cooperation among multiple centers, including internationally
-
Press releaseMore Women in Science: Biotechnology as a Driving Force to Close the Gender Gap
Women remain underrepresented in key sectors of the Fourth Industrial Revolution, accounting for only 22% of professionals in artificial intelligence, 28% in engineering, and 40% in computer science
-
Press releaseBiotechnology in the fight against cancer: from smart vectors to protein disorder as a the...
Biotechnology makes it possible to identify specific biomarkers and translate this knowledge into more effective and safer targeted therapies, improving clinical outcomes and quality of life
-
Press releaseBiotechnological innovation: key to healthier soils and resilient agricultural production
The EU has approved Directive (EU) 2025/2360 and the report EU Agricultural Outlook 2025–2035, establishing key soil health indicators and promoting more sustainable and efficient agricultural models
-
Press releaseThe 4th AseBio – TERAV – CIBER Forum examines how to boost value chains in advanced therap...
Advanced therapies offer new therapeutic options for complex diseases and also represent a strategic asset due to their contribution to knowledge, employment, and technological innovation. Their
-
Press releaseSalamanca to host the Green Innovation Forum 2026
The sixth edition, organized by AseBio and the Salamanca City Council, will take place on April 21 at the Castilla y León Conference and Exhibition Centre. The forum has positioned itself as a unique
-
Press releaseCristina Nadal, Executive Director of Government Affairs at MSD Spain, appointed new Presi...
At AseBio’s General Assembly, the new Vice Presidents were also elected: Rocío Arroyo (Amadix), Santiago de Torres (Atrys), and Carlota Gómez de la Hoz (Hipra). The AseBio General Assembly also
-
Press releaseAseBio positively assesses the foundations of the Biotech Act proposal
Following its recent launch, it aims to boost Europe’s biotechnological potential and accelerate the transition from research to market, while strengthening the EU’s industrial capacity and strategic
-
Press releaseAseBio and FATE sign an agreement to boost innovation in biotechnology, foodtech and agrit...
The agreement responds to the complementarity of objectives and lines of work between both organizations and reinforces AseBio’s commitment to sustainable agriculture and food innovation. AseBio and
-
Press releaseThe European sector urges the EU to avoid new restrictions and to conclude a coherent, sci...
The third and final round of trilogues begins to finalize an agreement on the Regulation on plants obtained through New Genomic Techniques (NGTs) and the food and feed derived from them. After months
-
Press releaseAdigital, AESEMI and AseBio drive a joint proposal to position Spain at the forefront of d...
The three national associations have submitted a joint document to the Ministry of Science, Innovation and Universities containing 13 concrete proposals to respond to the public consultation and guide
-
Press releaseBiotechnology, key to curbing antimicrobial resistance and strengthening European health s...
In 2021, antimicrobial resistance was involved in at least 4.7 million deaths worldwide, including 35,000 annual deaths in Europe and around 4,000 in Spain. The WHO warns of a sustained increase in
-
Press releaseA 20% increase in survival through early diagnosis: biotechnology accelerates change in th...
Low-dose CT screening can significantly reduce mortality and increase patient survival by around 20%, according to international scientific evidence Biotechnology is revolutionising lung cancer
-
Press releaseInnovation, research, and the future: biotechnology sets the course for psoriasis treatmen...
Biotechnology enables the development of more effective and personalized treatments for chronic inflammatory diseases such as psoriasis, improving the quality of life for millions of people. Inhibitec